A detailed history of Concurrent Investment Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 3,340 shares of BIIB stock, worth $612,789. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,340
Previous 3,386 1.36%
Holding current value
$612,789
Previous $785 Million 17.52%
% of portfolio
0.02%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$189.07 - $236.8 $8,697 - $10,892
-46 Reduced 1.36%
3,340 $647 Million
Q2 2024

Jul 30, 2024

BUY
$190.52 - $236.72 $74,112 - $92,084
389 Added 12.98%
3,386 $785 Million
Q1 2024

May 07, 2024

BUY
$212.02 - $267.71 $332,235 - $419,501
1,567 Added 109.58%
2,997 $646 Million
Q4 2023

Apr 15, 2024

BUY
$222.59 - $267.94 $318,303 - $383,154
1,430 New
1,430 $370 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $26.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.